You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cabozantinib

Showing 1 - 25 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

Not yet recruiting
  • RCC
  • Renal Cell Carcinoma
  • Cabozantinib 80 MG
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 3, 2023

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Nivolumab
  • +5 more
  • (no location specified)
Aug 21, 2023

Ewing Sarcoma, Osteosarcoma Trial in San Francisco, Aurora, Philadelphia (Cabozantinib)

Recruiting
  • Ewing Sarcoma
  • Osteosarcoma
  • Cabozantinib
  • San Francisco, California
  • +4 more
Nov 24, 2023

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Refractory Soft Tissue Sarcomas
  • Cabozantinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Tucson (Cabozantinib + Atezolizumab)

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Cabozantinib + Atezolizumab
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 14, 2022

Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

Recruiting
  • Neuroblastoma
  • +2 more
  • Cabozantinib
  • Columbus, Ohio
    Nationwide Children's Hospital
Dec 20, 2022

d To Treat People With Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Cancer
  • Cabozantinib
  • Tokyo, Japan
    Takeda Selected Site
Dec 5, 2022

Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC

Active, not recruiting
  • Metastatic Carcinoma in the Adrenal Cortex
  • +3 more
  • Cabozantinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Metastatic Soft-tissue Sarcoma Trial in United States (Cabozantinib, Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Cabozantinib
  • +2 more
  • Stanford, California
  • +3 more
Jan 10, 2023

Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)

Recruiting
  • Metastatic Squamous Non-Small Cell Lung Carcinoma
  • Cabozantinib 40 MG
  • Pembrolizumab 200mg
  • Chicago, Illinois
    University of Illinois at Chicago
Jan 20, 2023

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)

Recruiting
  • Germ Cell Tumor
  • +3 more
  • Cabozantinib
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Nov 16, 2022

Melanoma Trial in Washington, Baltimore, Hackensack (Nivolumab, Ipilimumab, Cabozantinib)

Suspended
  • Melanoma
  • Washington, District of Columbia
  • +2 more
Jan 18, 2023

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Cabozantinib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Cabozantinib
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Nov 10, 2022

Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

Active, not recruiting
  • Carcinoid Tumor
  • Pancreatic Neuroendocrine Tumor
  • Cabozantinib
  • Boston, Massachusetts
  • +1 more
Jul 15, 2022

Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Kansas City, Kansas
  • +3 more
May 12, 2023

Merkel Cell Carcinoma, Skin Cancer Trial in Boston (Cabozantinib)

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Cabozantinib
  • Boston, Massachusetts
  • +1 more
Jul 13, 2022

HCC Trial in Hong Kong, Seoul (Cabozantinib)

Active, not recruiting
  • HCC
  • Cabozantinib
  • Hong Kong, Hong Kong
  • +1 more
Jun 27, 2022

Esophageal Cancer, Metastatic Cancer, Squamous Cell Carcinoma Trial in Taipei City (Cabozantinib 40 MG, Atezolizumab Injection)

Recruiting
  • Esophageal Cancer
  • +2 more
  • Cabozantinib 40 MG
  • Atezolizumab Injection
  • Taipei City, Taiwan
    National Taiwan University Hospital
Sep 15, 2022

Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Cabo + Dostarlimab
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Autologous alpha-DC1/TBVA vaccine
  • Cabozantinib
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

Terminated
Has Results
  • Glioblastoma Multiforme
  • +3 more
  • Cabozantinib
  • Indianapolis, Indiana
    Riley Hospital for Children at IU Health
Jul 21, 2022

Prostate Cancer, Prostate Cancer Adenocarcinoma, Non-Metastatic Trial in Durham (Cabozantinib, Radical Prostatectomy)

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • Cabozantinib
  • Radical Prostatectomy
  • Durham, North Carolina
    Duke University Medical Center
Jun 3, 2022

Metastatic Renal Cell Carcinoma, Brain Metastases Trial in United States (drug, device, radiation)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Brain Metastases
  • Cabozantinib
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 10, 2023